Efficacy of rosuvastatin and atorvastatin in the treatment of elderly coronary heart disease
瑞舒伐他汀与阿托伐他汀治疗老年冠心病效果

摘要

目的 探讨在冠心病老年患者治疗中应用瑞舒伐他汀和阿托伐他汀，对疗效的影响。方法 试验者是2021年1月至2023年1月在医院治疗的80例冠心病老年患者，以随机信封法分为对照组与观察组，每组的例数均为40例，对照组采取阿托伐他汀，观察组采取瑞舒伐他汀，比对两组临床疗效与血脂水平。结果 观察组总疗效率高于对照组，P＜0.05；观察组血脂水平低于对照组，P＜0.05。结论 以瑞舒伐他汀治疗，可缓解患者症状，进一步增强疗效的同时，还能起到降低患者体内血脂水平的作用，临床借鉴价值较高。

Abstract

Objective: To investigate the effect of rosuvastatin and atorvastatin in the treatment of elderly patients with coronary heart disease (CHD).
Methods: The subjects were 80 elderly patients with coronary heart disease treated in hospital from 2021.01 to 2023.01. They were divided into control group and observation group by random envelope method, with 40 cases in each group. Atorvastatin was taken in the control group and rosuvastatin was taken in the observation group, and the clinical efficacy and lipid levels of the two groups were compared.
Results: The total therapeutic efficiency of the observation group was higher than that of the control group (P<0.05); The blood lipid level in the observation group was lower than that in the control group (P<0.05); The indexes of cardiac function in the observation group were better than those in the control group (P<0.05); The quality of life in the observation group was higher than that in the control group (P<0.05).
Conclusion  : Rosuvastatin treatment can relieve the symptoms of patients, further enhance the curative effect, but also play a role in reducing the blood lipid level of patients, which is of high clinical reference value.